Delivery Order SPE2DB20D1004-SPE2DB21FE8R3
- Not listed
- This federal contract award is for a prime vendor pharmaceutical distribution contract with the Defense Logistics Agency (DLA) awarded to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract, valued at $1,372.24, is a delivery order under an Indefinite Delivery Contract (IDC) held by Cencora, Inc. with the DLA Troop Support Medical worth up to $999,999,999.00. The IDC, which runs through November 2026, enables the DLA to efficiently procure a comprehensive range of...
- This federal contract award is for a Prime Vendor Pharmaceutical Branch-Philadelphia delivery order valued at $4,632.00, awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a performance period through May 20, 2021 and is a firm fixed price delivery order. Amerisourcebergen, through its parent company Cencora, Inc., holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with the...
- This federal contract award is for a Prime Vendor Pharmaceutical Branch in Philadelphia, awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distribution company. The contract, valued at $1,277.94, is a Delivery Order under the company's Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which has a potential value of up to $999,999,999.00 and runs through November 2026. This IDC serves as the primary vehicle for...
- The U.S. Defense Logistics Agency (DLA) awarded a delivery order contract to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, to provide a Prime Vendor Pharmaceutical Branch-Philadelphia. The contract, valued at $2,004.54, is a firm-fixed-price delivery order with a completion date of January 12, 2021. AmerisourceBergen, a subsidiary of the parent company Cencora, Inc., holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical to...
- The federal contract award is for a Prime Vendor Pharmaceutical Branch in Philadelphia, valued at $23,512.10. The contract was awarded to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract is a delivery order under an Indefinite Delivery Contract (IDC) with the Defense Logistics Agency (DLA) Troop Support Medical, valued at up to $999,999,999.00 and running through November 2026. This IDC serves as the primary vehicle for Amerisourcebergen to deliver a...
- This federal contract award is for a Prime Vendor Pharmacy Branch in Philadelphia, awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distribution company and subsidiary of Cencora, Inc. The contract, valued at $7,338.23, is a Firm Fixed Price Delivery Order awarded by the Defense Logistics Agency (DLA) to support military treatment facilities, veterans' healthcare programs, and other federal medical institutions. The contract covers a wide range of pharmaceutical products and...
- The U.S. Defense Logistics Agency (DLA) awarded a $45,349.55 Firm Fixed Price delivery order contract to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, to provide a Prime Vendor Pharmacy Branch in Philadelphia. The contract has no set-aside designation and runs through February 2021. Amerisourcebergen is a subsidiary of the parent company Cencora, Inc., which holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical to deliver a comprehensive...
- This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is for the provision of a prime vendor pharmaceutical branch in Philadelphia for the Defense Logistics Agency (DLA). The $11,636.45 delivery order contract has a firm fixed price and runs through November 2020. Amerisourcebergen, a subsidiary of the parent company Cencora, Inc., holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical to supply a...
- This federal contract award is for a "Prime Vendor Pharm Branch-Philadelphia" delivery order valued at $13,774.42, awarded to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is a firm-fixed-price delivery order with the Defense Logistics Agency (DLA), a defense agency. This order is part of Amerisourcebergen's larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which provides a comprehensive range of pharmaceutical products...
- This federal contract award is for a Prime Vendor Pharmaceutical Branch in Philadelphia, valued at $2,100.84. The contract was awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, on December 15, 2020. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) held by Amerisourcebergen's parent company, Cencora, Inc., with the DLA Troop Support Medical. This IDC is valued at up to $999,999,999.00 and runs through...
- SPE2DB20D1004Indefinite Delivery Contract
- SPE2DB20D1004-SPE2DB21FE8R3Delivery Order
This federal contract award from the Defense Logistics Agency (DLA) is for a Prime Vendor Pharmaceutical Branch in Philadelphia. The contract, valued at $2,309.23, was awarded to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00, which runs through November 2026. This IDC serves as the primary vehicle for Amerisourcebergen to provide a comprehensive range of pharmaceutical products and medical supplies, including specialty medications, brand-name and generic drugs, vaccines, syringes, vials, and test kits, to support military treatment facilities, veterans' healthcare programs, and other federal medical institutions. The contract does not have a set-aside designation, indicating full and open competition.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.3k | 11/20/20 |